Condition
Pericardial Disease
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Recruiting1
Enrolling By Invitation1
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04843371Recruiting
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
NCT06952179Completed
Pericardial Histopathology and COVID-19 Seropositivity
NCT06761872Not Yet RecruitingPrimary
Predisposing Factors and Prevalence of Pericardial Diseases Among ESRD Patients Who Are Admitted in Critical Care Medicine Unit in Assuit University Hospital
NCT06293924Enrolling By Invitation
Pericardial Fluid Analysis in Recurrent Pericarditis
Showing all 4 trials